Shop
eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
November 14 2024
Exciting research is being done in the burgeoning field called Metabolic Psychiatry, which is dedicated to addressing the bioenergetic underpinnings o...
A paper published recently in The New England Journal of Medicine noted the not-exactly surprising finding that over fifty percent of incident cardiovascular disease and approximately twenty percent of deaths from any cause may be attributable to five modifiable risk factors: body mass index (BMI), systolic blood pressure, non-HDL cholesterol, current smoking, and diabetes.
What is a bit more revealing is that these five risk factors were associated with quite different hazard ratios for both cardiovascular disease (CVD) and all-cause mortality. Compared to BMI, non-HDL cholesterol, and systolic blood pressure, the hazard ratios associated with diabetes and current smoking were far higher, with diabetes more than doubling the risk among certain age groups.
This finding suggests – as does a growing body of other evidence – that focusing on reversing type 2 diabetes (and the underlying insulin resistance) may be a more fruitful pursuit for preventing or reducing the incidence of CVD as opposed to using non-HDL cholesterol as a key marker of cardiovascular health. Additionally, compared to non-HDL cholesterol (even at levels above 200 mg/dL), BMI, systolic blood pressure, and diabetes all appeared to confer far greater risk for all-cause mortality. Since obesity, hypertension, and elevated glucose are part of the diagnostic criteria for metabolic syndrome, addressing this – rather than targeting elevated cholesterol – may have a bigger positive impact on a patient’s health trajectory.
For this research, data were pooled from around the world (34 countries across six continents) and encompassed over 1.5 million participants (54 percent women; median age of 54.4 years), so these were diverse population groups.
It’s not news that addressing lifestyle factors is likely the best way to reduce cardiovascular risk and improve overall health. But this research suggests that prioritizing certain factors over others may be warranted for those who are unable to change everything simultaneously.
Submit this form and you'll receive our latest news and updates.
A new study published in the Journal of the American College of Cardiology provides some mechanistic insight into the be...
Learn moreA series of papers published recently in Current Opinion in Endocrinology, Diabetes and Obesity highlights the growing d...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment